Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank93
3Y CAGR+69.9%
5Y CAGR+44.1%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+69.9%/yr
Annual compound
5Y CAGR
+44.1%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
6.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.65M | -27.7% |
| 2024 | $20.27M | +55.4% |
| 2023 | $13.04M | +337.0% |
| 2022 | $2.98M | +561.9% |
| 2021 | $451000.00 | -80.9% |
| 2020 | $2.36M | -74.7% |
| 2019 | $9.32M | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $813000.00 | +9.1% |
| 2016 | $745000.00 | - |